- Home
- AEHL vs IMRN Comparison
AEHL vs IMRN Comparison
Compare AEHL & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEHL
- IMRN
- Stock Information
- Founded
- AEHL 1993
- IMRN 1994
- Country
- AEHL China
- IMRN Australia
- Employees
- AEHL N/A
- IMRN N/A
- Industry
- AEHL Building Materials
- IMRN Biotechnology: Pharmaceutical Preparations
- Sector
- AEHL Industrials
- IMRN Health Care
- Exchange
- AEHL Nasdaq
- IMRN Nasdaq
- Market Cap
- AEHL 17.3M
- IMRN 14.4M
- IPO Year
- AEHL 2007
- IMRN N/A
- Fundamental
- Price
- AEHL $1.85
- IMRN $2.10
- Analyst Decision
- AEHL
- IMRN
- Analyst Count
- AEHL 0
- IMRN 0
- Target Price
- AEHL N/A
- IMRN N/A
- AVG Volume (30 Days)
- AEHL 327.4K
- IMRN 96.3K
- Earning Date
- AEHL 12-26-2025
- IMRN 08-29-2025
- Dividend Yield
- AEHL N/A
- IMRN N/A
- EPS Growth
- AEHL N/A
- IMRN N/A
- EPS
- AEHL N/A
- IMRN N/A
- Revenue
- AEHL $98,773,000.00
- IMRN $4,777,422.00
- Revenue This Year
- AEHL N/A
- IMRN N/A
- Revenue Next Year
- AEHL N/A
- IMRN N/A
- P/E Ratio
- AEHL N/A
- IMRN N/A
- Revenue Growth
- AEHL 36.99
- IMRN 48.63
- 52 Week Low
- AEHL $1.79
- IMRN $1.50
- 52 Week High
- AEHL $15.60
- IMRN $2.48
- Technical
- Relative Strength Index (RSI)
- AEHL 29.75
- IMRN 49.77
- Support Level
- AEHL $2.76
- IMRN $2.09
- Resistance Level
- AEHL $3.14
- IMRN $2.24
- Average True Range (ATR)
- AEHL 0.47
- IMRN 0.13
- MACD
- AEHL -0.18
- IMRN -0.02
- Stochastic Oscillator
- AEHL 0.00
- IMRN 30.00
About AEHL Antelope Enterprise Holdings Limited
Antelope Enterprise Holdings Ltd operates in two reportable operating segments: 1) business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting, and 2) natural gas power generation, which was in the initial development stage. The business of the Company is engaged in the PRC and U.S.
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.